Back to Search Start Over

Empirical Model Variability: Developing a new global optimisation approach to populate compression and compaction mixture rules.

Authors :
Tait T
Salehian M
Aroniada M
Shier AP
Elkes R
Robertson J
Markl D
Source :
International journal of pharmaceutics [Int J Pharm] 2024 Sep 05; Vol. 662, pp. 124475. Date of Electronic Publication: 2024 Jul 15.
Publication Year :
2024

Abstract

This study systematically evaluated the predictive accuracy of common empirical models for pharmaceutical powder compaction. A dataset of nine placebo and twelve active pharmaceutical ingredient (API) loaded blend formulations (four APIs at three drug loadings) was fitted to the widely used empirical tablet compression (Gurnham, Heckel, and Kawakita) and compaction (Ryshkewitch-Duckworth and Leuenberger) models. At low API loadings (<20w/w%), all models achieved R <superscript>2</superscript> above 90 % and RRMSE (relative root mean squared error) below 0.1. However, as API loads increased, overall model performance decreased, notably in the Heckel model. A parameter variability analysis identified multiple parameter pairs achieving acceptable fits. Consequently, a novel global optimization approach was developed populating arithmetic, geometric, and harmonic mixture rules for empirical tuning parameters. This method outperformed the traditional line of best fit approach. A cross validation study revealed that this method is capable of predicting tuning parameters which achieve an acceptable Goodness of Fit for new blends. Finally, with the restriction of maintaining consistent parameters for the placebo blend, the proposed method could substantially reduce the experimental requirements and API consumption for the exploration of new blends.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Daniel Markl reports financial support was provided by GlaxoSmithKline Research & Development Limited. Daniel Markl reports financial support was provided by Scottish Funding Council. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.].<br /> (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-3476
Volume :
662
Database :
MEDLINE
Journal :
International journal of pharmaceutics
Publication Type :
Academic Journal
Accession number :
39019299
Full Text :
https://doi.org/10.1016/j.ijpharm.2024.124475